The aim of this platform is to demonstrate the bio-safety and efficacy of drugs in development for use with animal models.
		Neuron BioPharma analyses the bio-safety of its compounds and any possible adverse effects they may cause in research models. The company uses cell cultures as well as zebrafish, whose characteristics allow us to rule out quickly those compounds that present any toxic effect. All these studies are carried out under the strictest international norms with techniques that minimize the use of experimentation on animals. Neuron BioPharma carries out compound efficacy studies in various animal models of increasing complexity: zebrafish, mice and rats. The company’s resources include a wide range of techniques for studying the effects of the various substances to be evaluated on the phenomenon of neurodegeneration and ageing. Moreover, the Neuron BioPharma research team analyses what happens with the compound from the moment of administration to its total elimination from the body (pharmacokinetics) and its biochemical and physiological effects (pharmacodynamics).
		Behaviour and memory To complement the studies already described Neuron BioPharma also uses techniques for the effective analysis of its compounds on memory, behaviour and the mobility of the animals with which it works. It also possesses the latest technologies available for animal behavioural studies, all of which are applied by a professional team of experts in this field.
		Regulation on animal experimentation